Electronic ‘nose’ can predict response to lung cancer immunotherapy

Researchers at the Amsterdam University Medical Centers have developed an electronic nose (eNose) that detects chemicals in the breath of lung cancer patients, distinguishing those who will and will not respond to therapy.